Fol. Biol. 2008, 54, 40-45
https://doi.org/10.14712/fb2008054020040
The Influence of Two megsin Polymorphisms on the Progression of IgA Nephropathy
References
1. , F. (1995) The enigma PAI-2: Gene expression, evolutionary and functional aspects. Thromb. Haemostasis 74, 172-179.
2. , L. P., Lajoie, G., Sugar, L. (2001) Predicting progression in IgA nephropathy. Am. J. Kidney Dis. 38, 728-735.
<https://doi.org/10.1053/ajkd.2001.27689>
3. , P. I. (1998) Serpins and regulation of cell death. Results Probl. Cell Differ. 24, 63-89.
<https://doi.org/10.1007/978-3-540-69185-3_4>
4. , G. (2004) Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin. Nephrol. 24, 179-196.
<https://doi.org/10.1016/j.semnephrol.2004.01.001>
5. , L., Sainna, Y., Giorgi, R. (2000) Tubular lesions determine prognosis of IgA nephropathy. Am. J. Kidney Dis. 35, 13-20.
<https://doi.org/10.1016/S0272-6386(00)70295-2>
6. , M., Martin, J., Thomas, G. J., Lovett, D. H. (1992) Proteinases and glomerular matrix turnover. Kidney Int. 41, 671-678.
<https://doi.org/10.1038/ki.1992.103>
7. , J. V., Bergstralh, E. J., Grande, J. P. (2002) Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol. Dial. Transplant. 17, 1197-1203.
<https://doi.org/10.1093/ndt/17.7.1197>
8. , D. T., McCoy, R. D., Zheng, X., Fay, W. P., Shen, T., Ginsburg, D. (1996) Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J. Clin. Invest. 97, 232-237.
<https://doi.org/10.1172/JCI118396>
9. , S., Narita, I., Saito, N., Watanabe, Y., Yamazaki, H., Sakatsume, M., Shimada, H., Nishi, S., Ueno, M., Akazawa, K., Arakawa, M., Gejyo, F. (2002) A(-20)C polymorphism of the angiotensinogen gene and progression of IgA nephropathy. Kidney Int. 62, 980-985.
<https://doi.org/10.1046/j.1523-1755.2002.00517.x>
10. , S. I., Ramirez, S. B., Winn, M. P., Bonventre, J. V., Owen, W. F. (2000) Evidence for genetic factors in the development and progression of IgA nephropathy. Kidney Int. 57, 1818-1835.
<https://doi.org/10.1046/j.1523-1755.2000.00032.x>
11. , R., Miyata, T., Suzuki, D., Toyoda, M., Wada, T., Kurokawa, K. (2001) Specific tissue distribution of Megsin, a novel serpin, in the glomerulus and its up-regulation in IgA nephropathy. Biochem. Biophys. Res. Commun. 286, 1098-1106.
<https://doi.org/10.1006/bbrc.2001.5509>
12. , R., Miyata, T., Imasawa, T., Nangaku, M., Kurokawa, K. (2002a) Mesangial cell-predominant functional gene, megsin. Nephrol. Dial. Transplant. 17, (9) 32-33.
<https://doi.org/10.1093/ndt/17.suppl_9.32>
13. , R., Miyata, T., Nangaku, M., Ueyama, H., Takeyama, K., Kato, S., Kurokawa, K. (2002b) Transcriptional regulation of a mesangium-predominant gene, megsin. J. Am. Soc. Nephrol. 13, 2715-2722.
<https://doi.org/10.1097/01.ASN.0000033507.32175.FA>
14. , R., Miyata, T., Kurokawa, K. (2003) Mesangial cell-predominant functional gene, megsin. Clin. Exp. Nephrol. 7, 87-92.
<https://doi.org/10.1007/s10157-003-0228-0>
15. , R. J., Lovett, D., Lehrer, R. I., Couser, W. G., Klebanoff, S. J. (1994) Role of oxidants and proteases in glomerular injury. Kidney Int. 45, 352-359.
<https://doi.org/10.1038/ki.1994.45>
16. , Y. S., Kang, D., Kwon, D. Y. (2001) Uteroglobin gene polymorphisms affect the progression of immunoglobulin A nephropathy by modulating the level of uteroglobin expression. Pharmacogenetics 11, 299-305.
<https://doi.org/10.1097/00008571-200106000-00004>
17. , Y., Kokubo, T., Horii, A. (1997) Prognostic prediction of long-term clinical courses in individual IgA nephropathy patients. Nephrology 3, 35-40.
<https://doi.org/10.1111/j.1440-1797.1997.tb00186.x>
18. , E. K. O., Baker, M. S., Bunn, C. L. (1995) Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood 86, 4007-4024.
<https://doi.org/10.1182/blood.V86.11.4007.bloodjournal86114007>
19. , Y. K., Woo, K. T., Choong, H. L., Zhao, Y., Tan, H. B., Chong, S. M., Tan, E. K., Yap, H. K., Wong, K. S. (2004) Renin-angiotensin system gene polymorphisms: its impact on IgAN and its progression to end-stage renal failure among Chinese in Singapore. Nephron Physiol. 97, 1-8.
<https://doi.org/10.1159/000077596>
20. , Y., DU, Y., Li, C., Guo, H., Leung, J. C. K., Lam, M. F., Yang, N., Huang, F., Chen, Y., Fang, J., Maxwell, P. H., Lai, K. N., Wang, Y. (2004) Family-based association study showing that immunoglobulin A nephropathy is associated with the polymorphisms 2093C and 2180T in the 3’ untranslated region of the Megsin gene. J. Am. Soc. Nephrol. 15, 1739-1743.
<https://doi.org/10.1097/01.ASN.0000130858.00688.46>
21. , T., Nangaku, M., Suzuki, D. (1998) A mesangium predominant gene, megsin, is a new serpin upregulated in IgA nephropathy. J. Clin. Invest. 102, 828-836.
<https://doi.org/10.1172/JCI2450>
22. , I., Saito, N., Goto, S. (2002) Role of uteroglobin G38A polymorphism in the progression of IgA nephropathy in Japanese patients. Kidney Int. 61, 1853-1858.
<https://doi.org/10.1046/j.1523-1755.2002.00336.x>
23. , I., Goto, S., Saito, N., Song, J., Omori, K., Kondo, D., Sakatsume, M., Gejyo, F. (2003a) Angiotensinogen gene variation and renoprotective efficacy of renin-angiotensin system blockade in IgA nephropathy. Kidney Int. 64, 1050-1058.
<https://doi.org/10.1046/j.1523-1755.2003.00187.x>
24. , I., Goto, S., Saito, N., Song, J., Ajiro, J., Sato, F., Saga, D., Kondo, D., Akazawa, K., Sakatsume, M., Gejyo, F. (2003b) Interaction between ACE and ADD1 gene polymorphisms in the progression of IgA nephropathy in Japanese patients. Hypertension 42, 304-309.
<https://doi.org/10.1161/01.HYP.0000085193.25617.78>
25. , M. S., Pirie-Shepherd, S., Lane, W. S., Folkman, J. (1999) Antiantiogenic activity of the cleaved conformation of the serpin antithrombin. Science 285, 1926-1928.
<https://doi.org/10.1126/science.285.5435.1926>
26. , V., Finne, P., Fagerudd, J. (2002) Factors associated with progression of IgA nephropathy are related to renal function. A model for estimating risk of progression in mild disease. Clin. Nephrol. 58, 85-94.
<https://doi.org/10.5414/CNP58085>
27. , J., Sakatsume, M., Narita, I., Goto, S., Omori, K., Takada, T., Saito, N., Ueno, M., Gejyo, F. (2003) Peroxisome proliferator-activated receptor γ C161T polymorphisms and survival of Japanese patients with immunoglobulin A nephropathy. Clin. Genet. 64, 398-403.
<https://doi.org/10.1034/j.1399-0004.2003.00154.x>
28. , D., Miyata, T., Nangaku, M., Takano, H., Saotome, N., Sakai, H. (1999) Expression of Megsin mRNA, a novel mesangium-predominant gene, in the renal tissues of various glomerular diseases. J. Am. Soc. Nephrol. 10, 2606-2613.
<https://doi.org/10.1681/ASN.V10122606>
29. , J., Huang, X. H., Mustonen, J., Koivula, T., Lehtimaki, T., Pasternack, A. (2000a) Angiotensin-converting enzyme insertion/deletion polymorphism and prognosis of IgA nephropathy. Nephron 86, 115-121.
<https://doi.org/10.1159/000045728>
30. , J., Mustonen, J., Pasternack, A. (2000b) Hypertriglyceridemia and hyperuricemia are risk factors for progression of IgA nephropathy. Nephrol. Dial. Transplant. 15, 34-42.
<https://doi.org/10.1093/ndt/15.1.34>
31. , T., Bahring, S., Kovací, T., Vas, T., Salomon, C., Busjahn, A., Luft, F. C., Nagy, J. (2000) Association of a uteroglobin polymorphism with rate of progression in patiens with IgA nephropathy. Am. J. Kidney Dis. 36, 468-473.
<https://doi.org/10.1053/ajkd.2000.9786>
32. , Y., Li, Y., Du, Y., Yang, N., Li, C., Leung, J. C. K., Lam, M. F., Huang, W., Chen, S., Maxwell, P. H., Lai, K. N., Wang, Y. (2006) Association of Megsin 2093C-2180T haplotype at the 3´untranslated region with disease severity and progression of IgA nephropathy. Nephrol. Dial. Transplant. 21, 1570-1574.
<https://doi.org/10.1093/ndt/gfk096>
